« Previous
Next »
Titles
- Deciphering the data: health insurance rates and rate review1
- Decline in serious events and wrong-drug reports involving opioids in Pennsylvania facilities1
- Delivering care anytime, anywhere: telehealth alters the medical ecosystem1
- Delivery reform1
- Demography is not destiny, revisited1
- Disability and employment: reevaluating the evidence in light of reporting errors1
- Distracted driving in Mississippi: an update1
- Do states adjust Medicaid enrollment in response to capitation rates?: evidence from the Medicare Part D clawback1
- Does Medicare Part D protect the elderly from financial risk?1
- Does public health insurance affect how much people work?1
- Drug control policy: information on status of federal efforts and key issues for preventing illicit drug use : testimony before the Committee on Oversight and Government Reform, House of Representatives1
- Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters1
- Drug shortages: shortchanging quality and safe patient care1
- Duke University Hospital: organizational and tactical strategies to enhance patient satisfaction1